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Q: What is the DAT? 
A: Also known as Coombs test, DAT detects IgG or com-
plements coating the surface of erythrocytes (direct) or 
IgG directed at erythrocytes in plasma (indirect).
Seven days later, she returned to the emergency depart-
ment (ED) with complaints of progressive back pain and 
dark urine for two days. Previous history of dark urine 
was denied. Significant findings included a temperature 
of 101oF, scleral icterus, and pale frenulum. Vaginal 
bleeding was noted but hepatosplenomegaly or costo-
vertebral angle tenderness were not elicited. Laboratory 
results are shown in Table 1. Peripheral smear showed 
slight microcytosis with moderate hypochromia and 
hemoglobinuria was inconclusive because numerous 
RBCs were found on urinary analysis. Computed tomog-
raphy (CT) scanning of abdomen and pelvis showed no 
evidence of occult bleed. The initial working diagnosis 
in the emergency room was hemolytic uremic syndrome 
(HUS) and two units of PRBC were requested given her 
symptomatic anemia. 
Q: What is the triad of HUS? 
A: Hemolytic anemia, thrombocytopenia, and acute 
renal failure. 
However, before the PRBC was given, further discus-
sions with the patient revealed a recent transfusion 
history, raising the suspicion of an alloantibody etiol-
ogy. A DAT was ordered, which was negative (Table 1). 
Continued suspicion prompted an eluate study result-
ing in detection of anti-E, anti-K, and a new anti-Jkb 
antibody. Phenotyping of two units of PRBC transfused 
seven days prior were all positive for Jkb antigen, con-
firming that anti-Jkb was the etiology of her hemolysis. 
Subsequently, two units of PRBCs negative for antigens 
Jkb, E, and K were given. The acute renal failure and the 
markers of hemolysis improved with supportive care, 
and she received a transfusion card prior to leaving the 
hospital. 
DISCUSSION
Delayed hemolytic transfusion reactions usually occur 
between one and four weeks post-transfusion (Beers 
et al., 2006) and represent approximately 11% of all 
complications of RBC transfusions (Talano et al., 2003). 
The mechanism is due to alloantibodies formed against 
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ABSTRACT
One-third of delayed hemolytic transfusion reactions 
(DHTR) are mediated by the Kidd antibody. We report 
a case of Kidd-induced DHTR, detailing the diagnostic 
dilemma in a patient presenting with nonspecific symp-
toms and inconclusive data. The importance of a full 
history, including a transfusion history, is emphasized to 
overcome the dilemma and concludes with a literature 
review of Kidd (type anti-Jkb) antibodies. 
INTRODUCTION
Transfusions are a common therapeutic modality in all 
areas of medicine. Modern blood banking interventions 
have ameliorated the frequency and severity of compli-
cations such as iron overload, infections, and immuno-
logical reactions (Klein et al., 2007). 
Many physicians are familiar with the acute transfusion 
complications. However, DHTR, characterized as an ana-
mnestic antibody response from re-exposure to a for-
eign red blood cell (RBC) antigen (Solanki and McCurdy, 
1978), is not as well known. Therefore, DHTR can result 
in significant morbidity and mortality. 
CASE REPORT
A 40-year-old Jamaican female (G1P1, or one pregnancy 
and one live birth) with fibroids presented with 
palpitations six months prior to admission. She was 
blood type O+ with no prior history of transfusions. 
The patient was diagnosed with iron deficiency anemia 
secondary to menorrhagia, transfused with two units of 
packed red blood cells (PRBC), and discharged with iron 
supplementation. 
 
Q: Besides transfusions, what other relevant histories 
should be considered as a source of foreign antigens? 
A: Pregnancies and transplantations. 
Six months later, she presented with complaints of 
dyspnea and fatigue. Hemoglobin was 6.2 g/dL and 
serology detected anti-E and anti-K antibodies (Table 
1). Direct antiglobulin test (DAT) was negative. She was 
transfused with two units of antigen E and K negative 
PRBCs and discharged the following day. 
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nature and occasionally difficult in vitro detection of 
this complication (Issitt and Anstee, 1998). Therefore, 
Kidd antibody–induced DHTR represents a diagnostic 
challenge for the clinician (Honig and Bove, 1980).
Hematologic etiologies with similar presentations 
include sickle cell anemia, glucose-6-phophate dehydro-
genase (G6PD) deficiency, and HUS. Sickle cell anemia 
should be considered in an African American individual 
who presents with back pain and dark urine; however, 
indirect bilirubin should be elevated due to chronic 
hemolysis. The absence of sickle cells on peripheral 
smear makes this diagnosis unlikely in this case. Red cell 
enzyme deficiency such as G6PD was also considered in 
this patient, but a peripheral smear usually reveals bite 
cells and none were found. Additionally, G6PD is an 
X-linked disorder predominantly seen in males (Dhaliwal 
et al., 2004). HUS was the working diagnosis in the ED 
because of acute renal failure and hemolytic markers, 
but no evidence of thrombocytopenia and microangio-
pathic hemolytic anemia, which are classically observed 
in HUS (Razzaq, 2006), was observed in this patient. Our 
patient did have hemoglobinemia (Figure 1), but hema-
common foreign RBC antigens such as Rh, Kell, and Kidd 
(Stainsby et al., 2005). The eluate study in the appro-
priate clinical setting is diagnostic of DHTR (Engelfriet 
et al., 2006). Though self-limited, DHTR can cause 
shock, renal failure (Meltz et al., 1971), and dissemi-
nated intravascular coagulation (Pineda et al., 1978). 
Treatment includes aggressive hydration, diuretics, and 
avoidance of antigen-positive transfusions to minimize 
nephrotoxicity. Steroids and intravenous immunoglobu-
lin (IVIG) (Woodcock et al., 1993) have been used as 
treatments but their effectiveness requires further 
validation. Prevention strategies for DHTR include pro-
viding the patient with appropriate information via an 
antibody profile card or Medic Alert bracelet, maintain-
ing accurate hospital records, minimizing unnecessary 
blood transfusions, and using Rituximab in sickle cell 
populations (Noizat-Pirenne et al., 2007). 
The Kidd family of antigens (Jka, Jkb, and Jk3) was first 
described in 1951 (Allen et al., 1951), and is estimated to 
be responsible for more than one-third of DHTRs (Ness 
et al., 1990). The prevalence of Kidd antibody–induced 
DHTRs is likely underrepresented due to the transient 
Table 1: Selected Laboratory Values
Laboratory Test 6 Months Before Day -7 Day -5 On Admission* Day +1 Day +2 Day +3
Antibody Screen Negative Positive - Positive - - Positive
Eluate - Anti-E, K - Anti-E, K, JkB - - Anti-E
Direct Antigen Test - Negative - Negative - - Negative
Transfusion 2 2 - 2 - - -
Hemoglobin (g/dL) 6.6 6.2 8.8 6 8.7 8.3 8.3
Bilirubin T/l (mg/dL) - 0.1/NA - 1.6/1.5 - 0.24/NA -
Haptoglobin (mg/dL) - - - <20 - - <20
Lactate Dehydrogenase - - - 2461 - 2211 -
Creatine (mg/dL) 0.86 0.96 - 3.11 3.49 3.71 3.39
*(Grossly hemolyzed)
Table 2: Review of Literature
Patient  
Characteristics
Hemolysis Characteristics
References Age Sex Start Date Resolution Total Transfused Treatment
Hussain, SS et al. Transfus Med 2007; 17(3):197-9 66 Male 11 14 5 3 Steroids
Shahian, DM et al. Panminerva Med 1995; 37(2):95-7 74 Female 14 20 7 15 Supportive
Takeuchi, K et al. Thorac Cardiocasc Surg 1993; 41(2):104-6 42 Female 14 25 12 7 Supportive
Hollard, PV et al. JAMA 1968; 204:1007-8 50 Male 13 23 10 4 Supportive
Morgan, P et al. Transfusion 1967 Jul-Aug; 7(4):307-8 36 Female 4 16 13 13 Supportive
Kurtides, ES et al. JAMA 1966;197(10):816-7 58 Male 8 11 4 8 Supportive
Jamieson, AL et al. Am J Med Technol 1965 Nov-Dec; 31(6):397-401 39 Female 6 11 6 7 Supportive
Scudder, J et al. J Natl Med Assoc 1960 Mar; 52:75-80 38 Female 4 N/A N/A 5 Supportive
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turia could be secondary to catheter trauma or vaginal 
bleeding, obscuring the diagnosis. DHTR caused lysis of 
all previously transfused RBCs, explaining a negative 
DAT (Table 1) and the grossly hemolyzed blood samples 
(Figure 1). 
We reviewed eight cases of anti-Jkb DHTR reported in 
the English literature, shown in Table 2. Treatment was 
mainly supportive with one case reporting the use of 
steroids. The case treated with steroids had the lowest 
number of transfusions and second-shortest duration of 
hemolysis.
A complete clinical history, including a transfusion 
history, combined with appropriate laboratory data, 
allows for diagnosis and treatment of DHTR. The suspi-
cion of DHTR should be considered when patients have 
the clinical signs and symptoms outlined in Table 3. 
Appropriate management can improve morbidity and 
mortality.
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Table 3: Signs and Symptoms
Timeline 
>24 hrs post-transfusion, usually 5-7 days
Symptoms:
Jaundice
Malaise
Fever
Hemoglobinuria
Laboratory values:
Decrease Red Cell Mass
Decrease Haptoglobin
Increase Indirect Bilirubin
Increase Lactate Dehydrogenase
Increase Creatinine
Figure 1: Date of admission, day +1, and plasma control, which 
is negative for hemoglobimia (from left to right).
